Table 2.
Participant demographic and clinical characteristics
| Characteristic | (n=179) | |
|---|---|---|
| n | ||
|
| ||
| Male** | 117 | 65% |
| Race | ||
| Caucasian | 76 | 42% |
| African American | 94 | 53% |
| Native American | 1 | 1% |
| Asian | 4 | 2% |
| Other | 4 | 2% |
| Ethnicity | ||
| Hispanic | 37 | 21% |
| Non-Hispanic | 142 | 79% |
| Diagnosis | ||
| Schizophrenia | 96 | 54% |
| Schizoaffective | 83 | 46% |
| Medication type a | ||
| Typical | 26 | 15% |
| Atypical | 125 | 70% |
| Combination | 3 | 2% |
|
| ||
| Mean | SD | |
|
| ||
| Age (years) | 42.11 | 12.32 |
| Education (years) | 12.70 | 2.14 |
| Maternal Education (years) | 12.61 | 3.22 |
| WRAT-3 | 93.68 | 15.84 |
a
Nineteen individuals were not taking antipsychotic medications, and medication information was missing for 6 individuals.